PD Sessions @ Zoom: Supporting research across the ‘valley of death’: NFMRI’s strategy impact results.
PD Sessions @ Zoom: Supporting research across the ‘valley of death’: NFMRI’s strategy impact results.
In 2013, NFMRI chose to focus on assisting biomedical research to cross the ‘valley of death’ in order to next-step partners. After supporting a significant number of projects across Australia addressing various diseases and conditions, NFMRI moved beyond a growing number of case studies to being able to analyse the effectiveness of its strategy.
The Strategic Impact Report found that 62% of supported projects attracted next-step partners and have together leveraged funding of over $45m.
Join us for this interactive Q&A session to learn more about the important factors that have helped NFMRI and its researchers achieve success.
Please note that this session will not be recorded.
SESSION PRESENTER(S):
Dr Noel Chambers
CEO, National Foundation for Medical Research and Innovation
Noel was appointed as the Chief Executive Officer of the National Foundation for Medical Research and Innovation in April 2013. Noel has a PhD in pharmacology/medicinal chemistry from the University of Sydney. His work experience includes positions in research, research translation, commercialisation, start-up companies, biotechnology and philanthropy.
Dr Katherine Jackman
Investment Associate, Brandon Capital Partners
Prior to joining Brandon Capital Partners, Kath was based in academia working in the field of experimental stroke. She spent 5 years at Weill Cornell Medicine-New York Presbyterian Hospital as a NHMRC CJ Martin and American Australian Association Sir Keith Murdoch fellow, before returning to the Florey Institute in Melbourne. During her time in academia she secured competitive research funding from both the NHMRC and Brain Foundation of Australia. Kath is a director and Chief Operating Officer of Athena Medicines. Kath has a Bachelor of Science (Honours) from The University of Melbourne, a PhD in Pharmacology from the University of Melbourne and an MBA (Deans’ Honours list) from the Melbourne Business School.
A/Prof Peter van Wijngaarden
Deputy Director & Head of Ophthalmic Neuroscience, Centre for Eye Research Australia
Associate Professor Peter van Wijngaarden is an ophthalmologist and medical scientist with research interests in diabetic retinopathy, Alzheimer’s disease and retinal imaging biomarker discovery. He has research experience in retinal vascular biology and central nervous system regeneration.
CPD: Accredited members (ARMAs and ARMFs) will automatically accrue 1 CPD hour per session.
Zoom webinar link: To be provided in event confirmation.
Webinar ID: To be provided in event confirmation.
Help/FAQs: Click here for Zoom webinar instructions. If you need assistance with accessing Zoom at your office, please contact your organisation’s IT Support. We strongly recommend you test your ability to connect to Zoom prior to the session.
If you have any questions, please contact the ARMS Executive Office arms.adminofficer@flinders.edu.au or +61 8 8201 5592.
Should your circumstances change, and you are unable to attend this workshop, you must contact the arms.adminofficer@flinders.edu.au by no later than 10 working days prior to the commencement of the scheduled event. ARMS will refund the full registration fee minus any administrative fees.
Should you cancel less than 10 working days prior to the commencement of this workshop, no refund will be payable but instead you may wish to send a proxy.
ARMS reserve the right to cancel, postpone or re-schedule courses and events due to minimum numbers not being reached or for other unforeseen circumstances. In the event of a cancellation, ARMS will aim to advise all participants in writing five (5) days prior to the scheduled event and will refund the full registration fee including administrative charges within 30 days after notification.
